
Loading, please wait...

Loading, please wait...

Maintaining high standards in postgraduate endocrinology training is essential for superior patient outcomes. Recently, the European Society of Endocrinology (ESE) and the UEMS Section and Board of Endocrinology (SBE) conducted a comprehensive survey. This study evaluated the accreditation processes across 35 European countries. Notably, the data revealed significant variations in how different nations recognize and manage training centers. These differences impact how specialists are prepared for clinical practice across the continent.
The researchers gathered information from delegates representing various national endocrine societies. Consequently, they identified 767 training centers across 31 countries. However, an established accreditation process exists in only 27 of these nations. Furthermore, mandatory re-accreditation occurs in 22 countries at differing intervals. These intervals typically range from one to seven years. Such diversity in regulatory oversight suggests a need for more harmonized standards to ensure consistent educational quality.
Additionally, the survey highlighted the organization of training programs. Only thirteen countries currently implement a formal train-the-trainers programme. Moreover, the trainee-to-trainer ratio varies widely, reaching as high as 3:1 in some regions. Therefore, understanding these metrics is vital for estimating the future workforce of endocrinologists. Ultimately, these findings support the push for a unified European curriculum. Such a framework ensures optimal care for the growing number of patients with metabolic and endocrine diseases.
According to the UEMS SBE survey, accreditation processes exist in 27 out of 35 surveyed countries. However, the methods and re-accreditation intervals vary significantly between nations, ranging from one to seven years.
A unified curriculum helps harmonize training standards and facilitates professional mobility. It also ensures that a sufficient number of qualified specialists are trained to meet the demands of an increasing patient population.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional endorsement. Refer to the latest local and national guidelines for clinical practice.
References
Perrild H et al. Recognition and accreditation of postgraduate training centers in Endocrinology in Europe. Endocr Connect. 2026 May 18. doi: undefined. PMID: 42149651.
European Society of Endocrinology. ESE Curriculum and Training Recommendation in Endocrinology. 2024. Available at: ese-hormones.org.
Luger A et al. European Society of Endocrinology curriculum and European training Recommendations. Eur J Endocrinol. 2024;191(5):R71–R77.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive study across 35 European countries reveals significant variability in the accreditation and re-accreditation of endocrinology training cente...
5 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today